HealthQuant

Looking to find the perfect combination of strengths in KOLs and online influencers? Our latest blog post uncovers the secrets of multi-layered, segmented influencer lists. Stay tuned for expert insights! #KOL #MedAffairs #PharmaMarketing #MedTech buff.ly/3PhDGlB

This could come in handy!

Ahead of the @ASCO-2025, @Larvol CLIN spotlights the top companies driving the future of cancer research. Get the latest #ASCO25 updates as they happen: t.ly/7TCD6 #LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights | @ADesaiMD | @HHorinouchi | @DrRiyazShah | @FordePatrick | @lungoncdoc | @matteolambe | @ErikaHamilton9 | @PTarantinoMD | @DrChoueiri | @AndreaNecchi | @GillSharlene | @mtmdphd | @SuyogCancer

@tapshah21 Will do! Thank you, Tapan.

@HealthQuant Hey! Could you report in devcommunity.x.com ? Probably include your app id and the exact endpoint you're hitting with expected vs actual output. Thanks!

@tapshah21 Hi Tapan! Yesterday my app stopped returning user data when calling the X ID user endpoint. Nothing in the documentation implies that was intentionally deprecated; can you please help?

@isabelzam95 That's amazing - Congratulations!

I matched Hematology/Oncology at Mayo Clinic-AZ! It's been something I've been working towards for the past 12 years and, at times, seemed like a very far-fetched dream. I am so grateful & humbled to be able to be in this position and thrilled for the future. 🥳

PS I’ve had a Basic plan for a couple of years and have had no problems thus far …

@chrisparkX Chris, can you help me out? My app that makes API calls for user data based on Twitter ID stopped working yesterday. Documentation still says that should work w/my basic plan. Any ideas?

@XDevelopers It appears that you've changed the API endpoints for USER queries from the basic subscription. Can you confirm? That's not anywhere in the documentation.

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch. biopharmadive.com/news/obesity-d… #pharma #feedly via @BioPharmaDive

This is one to watch: Startup led by John Maraganore raises $135M to build ‘future of RNAi’ biopharmadive.com/news/city-ther… #pharma #feedly #biotech

2/2 But July, August and September of 2024 were each significantly higher than the same months in 2023. I'm encouraged that doctors are coming back. We'll keep watching! #MedTwitter #HCSM #HCSMEU

Interesting #MedTwitter stats: Comparing monthly twitter posts from global doctors, Posts from January-June of 2023 and 2024, physician posts were slightly down (February was actually up 2%). 1/2

Thanks @BioPharmaDive! Which conferences will YOU be attending? biopharmadive.com/news/top-biote… #Pharma #Biotech #PharmaMarketing

Man, that is a tough analysis - but it's hard to argue. We have to find different ways ...

Here are some things every guy should know about the most commonly diagnosed cancer in men. spr.ly/6013osbFb

Thanks to @JNJInnovMed for their Transparency Report - and to @brianreid's Cost Curve newsletter for pointing us to it!

Nice work by @EliLillyandCo on their #Olympics message: youtu.be/2paOxynX7aQ?si…

Did you ever wonder if cardiologists around the world are still active on X/Twitter? They are. Contact us at info@healthquant.com for more information! bit.ly/3XS3g5c

Indeed - #Pharma winds up looking like the bad guys - when they're really just taking the fall for out-of-control #PBMs.

This one absolutely does NOT pass the sniff test - rest assured that we'll be doing some fact-checking!! | Many docs who tweeted product endorsements also took money from manufacturers, analysis shows | by @pharmalot buff.ly/3yEASsP